SNDX-5613-0707: Expanded Access Program for SNDX-5613 in Patients with Relapsed/Refractory Acute Leukemias with Genetic Alterations Associated with HOXA Overexpression

Primary Objective

The primary objective of this expanded access program (EAP) is to provide early access to treatment with SNDX-5613 in patients with R/R acute leukemias.

Is this Study for You?

Let's Get Started!




Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Christine McMahon

Christine McMahon

Study ID

Protocol Number: 23-2063

More information available at NCT05918913


Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers